Therapeutic and diagnostic potential of urine-enriched molecular markers for high-risk prostate cancer in men Grant

Therapeutic and diagnostic potential of urine-enriched molecular markers for high-risk prostate cancer in men .

date/time interval

  • May 1, 2024 - April 30, 2027

awarded by

subcontracted through

sponsor award ID

  • PO #2006695122 / Prime Award # 24B16

contributor